Axogen, Inc. Finance Lease, Right-of-Use Asset, Amortization
Axogen, Inc. (AXGN) reported Finance Lease, Right-of-Use Asset, Amortization of $6.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2025-02-26
- Axogen, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2021-12-31 was $5.00K, a 0.00% change year-over-year.
- Axogen, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2021-09-30 was $6.00K, a 0.00% change year-over-year.
- Axogen, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2021-06-30 was $2.00K, a 66.67% decline year-over-year.
- Axogen, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2021-03-31 was $6.00K, a 20.00% increase year-over-year.
- Axogen, Inc. finance lease, right-of-use asset, amortization for fiscal 2024 was $6.00K, a 50.00% increase from fiscal 2023.
- Axogen, Inc. finance lease, right-of-use asset, amortization for fiscal 2023 was $4.00K, a 80.00% decline from fiscal 2022.
- Axogen, Inc. finance lease, right-of-use asset, amortization for fiscal 2022 was $20.00K, a 9.09% decline from fiscal 2021.
- Axogen, Inc. finance lease, right-of-use asset, amortization for fiscal 2021 was $22.00K, a 0.00% change from fiscal 2020.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|
| 2024-12-31 | $6.00K 10-K · filed 2025-02-26 | |||
| 2023-12-31 | $4.00K 10-K · filed 2025-02-26 | |||
| 2022-12-31 | $20.00K 10-K · filed 2025-02-26 | |||
| 2021-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $11.00K derived: sum of 2 quarters · filed 2024-03-05 | $13.00K derived: sum of 3 quarters · filed 2024-03-05 | $22.00K 10-K · filed 2024-03-05 |
| 2021-09-30 | $6.00K 10-Q · filed 2021-11-04 | $8.00K derived: sum of 2 quarters · filed 2021-11-04 | $17.00K 10-Q · filed 2021-11-04 | $19.00K derived: sum of 4 quarters · filed 2023-03-14 |
| 2021-06-30 | $2.00K 10-Q · filed 2021-08-05 | $8.00K 10-Q · filed 2021-08-05 | $13.00K derived: sum of 3 quarters · filed 2023-03-14 | $19.00K derived: sum of 4 quarters · filed 2023-03-14 |
| 2021-03-31 | $6.00K 10-Q · filed 2021-05-06 | $11.00K derived: sum of 2 quarters · filed 2023-03-14 | $17.00K derived: sum of 3 quarters · filed 2023-03-14 | $23.00K derived: sum of 4 quarters · filed 2023-03-14 |
| 2020-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $11.00K derived: sum of 2 quarters · filed 2023-03-14 | $17.00K derived: sum of 3 quarters · filed 2023-03-14 | $22.00K 10-K · filed 2023-03-14 |
| 2020-09-30 | $6.00K 10-Q · filed 2021-11-04 | $12.00K derived: sum of 2 quarters · filed 2021-11-04 | $17.00K 10-Q · filed 2021-11-04 | $23.00K derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $6.00K 10-Q · filed 2021-08-05 | $11.00K 10-Q · filed 2021-08-05 | $17.00K derived: sum of 3 quarters · filed 2022-02-25 | $23.00K derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $5.00K 10-Q · filed 2021-05-06 | $11.00K derived: sum of 2 quarters · filed 2022-02-25 | $17.00K derived: sum of 3 quarters · filed 2022-02-25 | $23.00K derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $12.00K derived: sum of 2 quarters · filed 2022-02-25 | $18.00K derived: sum of 3 quarters · filed 2022-02-25 | $22.00K 10-K · filed 2022-02-25 |
| 2019-09-30 | $6.00K 10-Q · filed 2020-10-30 | $12.00K derived: sum of 2 quarters · filed 2020-10-30 | $16.00K 10-Q · filed 2020-10-30 | |
| 2019-06-30 | $6.00K 10-Q · filed 2020-08-07 | $11.00K 10-Q · filed 2020-08-07 | ||
| 2019-03-31 | $5.00K 10-Q · filed 2020-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |